Drugs, driving and traffic safety in acute and chronic pain

  • Dieuwke S. Veldhuijzen
  • Anne Mieke Karsch
  • Albert J.M. van Wijck


Pain is a common reason for seeking health care and the economical burden of pain to society is high. Careful estimates state that 20% of the population has chronic pain, defined as pain which persists for a longer period, usually taken to be 3 or more months. Chronic pain severely disrupts various aspects of daily life. Unemployment, disability, and relational problems are frequently encountered among individuals with chronic pain. Chronic pain may have negative effects on driving ability. Effective treatment of pain is thus important, both in terms of improved quality of life of the patient and traffic safety. Several classes of pharmacological agents are being used to treat pain. Unfortunately with the currently available treatment options, pain is often not completely relieved. Furthermore, many of the pharmacological agents have side effects that may affect driving in its turn. This chapter provides an overview of the recent insights on the effects of pain and its treatment with pharmacological agents on driving ability and traffic safety.


Chronic Pain Chronic Pain Patient Traffic Safety Chronic Noncancer Pain DVVRFLDWHG ZLWK 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Merskey H, Bogduk N (eds.) (1994) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms, 2nd Edition. IASP Press, SeattleGoogle Scholar
  2. 2.
    Bromm B, Lorenz J (1998) Neurophysiological evaluation of pain. Clin Neurophysiol 107: 227–253CrossRefGoogle Scholar
  3. 3.
    Loeser JD, Melzack R (1999) Pain: an overview. Lancet 353: 1607–1609PubMedCrossRefGoogle Scholar
  4. 4.
    Gureje O, von Korff M, Simon G, Gater R (1998) Persistent pain and well-being. A World Health Organization Study in Primary Care. JAMA 280: 147–151PubMedCrossRefGoogle Scholar
  5. 5.
    Berkley KJ, Zalcman SS, Simon VR (2006) Sex and gender differences in pain and inflammation: a rapidly maturing field. Am J Physiol Regul Integr Comp Physiol 291: R241–244PubMedGoogle Scholar
  6. 6.
    Greenspan JD, Craft RM, LeResche L, Arendt-Nielsen L, Berkely KJ, Filligim RB, Gold MS, Holdcroft A, Lautenbacher S, Mayer EA, et al. (2007) Consensus working group of the Sex, Gender and Pain SIG of the IASP. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 132: S26–S45PubMedCrossRefGoogle Scholar
  7. 7.
    Breitvik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 10: 287–333CrossRefGoogle Scholar
  8. 8.
    Turk DC (2002) Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 18: 355–365PubMedCrossRefGoogle Scholar
  9. 9.
    Campbell LC, Clauw DJ, Keefe FJ (2003) Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry 54: 399–409PubMedCrossRefGoogle Scholar
  10. 10.
    Lame IE, Peters ML, Vlaeyen JW, Kleef M, Patijn J (2005) Quality of life in chronic pain is more associated with beliefs about pain, than with pain intensity. Eur J Pain 9: 15–24PubMedCrossRefGoogle Scholar
  11. 11.
    Severijns R, Vlaeyen JW, van den Hout MA, Picavet HS (2005) Pain catastrophizing and consequences of musculoskeletal pain: a prospective study in the Dutch community. J Pain 6: 125–132CrossRefGoogle Scholar
  12. 12.
    O’Hanlon JF, Haak TW, Blaauw GJ, Riemersma JB (1982) Diazepam impairs lateral position control in highway driving. Science 217: 79–81PubMedCrossRefGoogle Scholar
  13. 13.
    O’Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 18: S121–S129Google Scholar
  14. 14.
    Louwerens JW, Gloerich ABM, De Vries G (1987) The relationship between drivers’ blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij PC, Roszbach R (eds.): Alcohol, Drugs and Traffic Safety. Proceedings of the 10th International Conference on Alcohol, Drugs and Traffic Safety. Excerpta Medica, Amsterdam, 183–192Google Scholar
  15. 15.
    Kaszniak AW, Keyl PM, Albert MS (1991) Dementia and the older driver. Hum Factors 33: 527–537PubMedGoogle Scholar
  16. 16.
    Koepsell TD, Wolf M, McCloskey L, Buchner DM, Louie D, Wagner EH (1994) Medical conditions and motor vehicle collision injuries in older adults. J Am Geriatr Soc 42: 695–700PubMedGoogle Scholar
  17. 17.
    McGwin G, Sims RV, Pulley L, Roseman JM (2000) Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based casecontrol study. Am J Epidemiol 152: 424–431PubMedCrossRefGoogle Scholar
  18. 18.
    Guibert R, Duarte-Franco E, Ciampi A, Potvin L, Loiselle J, Philibert L (1998) Medical conditions and the risk of motor vehicle crashes in men. Arch Fam Med 7: 554–558PubMedCrossRefGoogle Scholar
  19. 19.
    Lagarde E, Chastang J-F, Lafont S, Coeuret-Pellicer M, Chiron M (2005) Pain and pain treatment were associated with traffic accident involvement in a cohort of middle-aged workers. J Clin Epidemiol 58: 524–531PubMedCrossRefGoogle Scholar
  20. 20.
    Eccleston C (1994) Chronic pain and attention: A cognitive approach. Br J Clin Psychol 33: 535–547PubMedGoogle Scholar
  21. 21.
    Eccleston C (1995) Chronic pain and distraction: an experimental investigation into the role of sustained and shifting attention in the processing of chronic persistent pain. Behav Res Ther 33: 391–405PubMedCrossRefGoogle Scholar
  22. 22.
    Grisart JM, Plaghki LH (1999) Impaired selective attention in chronic pain patients. Eur J Pain 3: 325–333PubMedCrossRefGoogle Scholar
  23. 23.
    Dick BD, Connolly JF, McGrath PJ, Finley GA, Stroink G, Houlihan ME, Clark AJ (2003) The disruptive effect of chronic pain on mismatch negativity. Clin Neurophysiol 114: 1497–1506PubMedCrossRefGoogle Scholar
  24. 24.
    Veldhuijzen DS, van Wijck AJM, Kalkman CJ, Kenemans JL, Olivier B, Volkerts ER (2006) Processing capacity in chronic pain patients: a visual event-related potentials study. Pain 121: 60–68PubMedCrossRefGoogle Scholar
  25. 25.
    Van Damme S, Crombez G, Eccleston C (2002) Retarded disengagement from pain cues: the effects of pain catastrophizing and pain expectancy. Pain 100: 111–118PubMedCrossRefGoogle Scholar
  26. 26.
    Houlihan ME, McGrath PJ, Connolly JF, Stroink G, Finley GA, Dick B, Phi TT (2004) Assessing the effect of pain on demands for attentional resources using ERPs. Int J Psychophysiol 51: 181–187PubMedCrossRefGoogle Scholar
  27. 27.
    Eccleston C, Crombez G, Aldrich S, Stannard C (1997) Attention and somatic awareness in chronic pain. Pain 72: 209–215PubMedCrossRefGoogle Scholar
  28. 28.
    Veldhuijzen DS, van Wijck AJ, Wille F, Verster JC, Kenemans JL, Kalkman CJ, Olivier B, Volkerts ER (2006) Effect of chronic nonmalignant pain on highway driving performance. Pain 122: 28–35PubMedCrossRefGoogle Scholar
  29. 29.
    Backonja MM (2003) Defining neuropathic pain. Anesth Analg 97: 785–790PubMedCrossRefGoogle Scholar
  30. 30.
    Kidd BL, Urban LA (2001) Mechanisms of inflammatory pain. Br J Anesth 87: 3–11CrossRefGoogle Scholar
  31. 31.
    Kandel ER, Schwartz JH, Jessell TM (2000) Principles of neural science. Fourth Edition. McGraw-Hill Companies, Inc, USAGoogle Scholar
  32. 32.
    Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ et al. (2007) Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 132: 237–251PubMedCrossRefGoogle Scholar
  33. 33.
    Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ (2001) Interleukin-1a-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410: 471–475PubMedCrossRefGoogle Scholar
  34. 34.
    McQuay H (1999) Opioids in pain management. Lancet 353: 2229–2232PubMedCrossRefGoogle Scholar
  35. 35.
    Kalso E, Edwards JE, Moore RA, McQuay HJ (2004) Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112: 372–80PubMedCrossRefGoogle Scholar
  36. 36.
    Moore RA, McQuay HJ (2005) Prevalence of opioid adverse events in chronic nonmalignant pain: systematic review of randomized trials of oral opioids. Arthr Res Ther 7: R104–R1051CrossRefGoogle Scholar
  37. 37.
    Hojsted J, Sjogren P (2007) Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 11: 490–518PubMedCrossRefGoogle Scholar
  38. 38.
    Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK (2006) Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 125: 172–179PubMedCrossRefGoogle Scholar
  39. 39.
    Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D (2003) Oral opioid therapy for chronic peripheral and central neuropathic pain. New Engl J Med 348: 1223–1232PubMedCrossRefGoogle Scholar
  40. 40.
    Kingery WS (1997) A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 73: 123–139PubMedCrossRefGoogle Scholar
  41. 41.
    Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118: 289–305PubMedCrossRefGoogle Scholar
  42. 42.
    Sindrup SH, Jensen TS (2001) Antidepressants in the treatment of neuropathic pain. In: Neuropathic pain: pathophysiology and treatment, Progress in pain research and management, Vol 21 Hansson PT, Fields HL, Hill RG, Marchettini P (eds.). IASP Press, SeattleGoogle Scholar
  43. 43.
    Veldhuijzen DS, Verster JC (2006) [Article in Dutch] Invloed van chronische pijn en de farmacologische behandeling van pijn op het rijgedrag van automobilisten. Modern Medicine 8: 45–48Google Scholar
  44. 44.
    Foley DJ, Wallace RB, Eberhard J (1995) Risk factors for motor vehicle crashes among older drivers in a rural community. J Am Geriatr Soc 43: 776–781PubMedGoogle Scholar
  45. 45.
    McGwin G, Sims RV, Pulley L, Roseman JM (2000) Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based casecontrol study. Am J Epidemiol 152: 424–431PubMedCrossRefGoogle Scholar
  46. 46.
    Bradley CM, Nicholson AN Studies on performance with aspirin and paracetamol and with the centrally acting analgesics meptazinol and pentazocine (1987) Eur J Clin Pharmacol 32: 135–139PubMedCrossRefGoogle Scholar
  47. 47.
    Verster JC, Veldhuijzen DS, Volkerts ER (2006) Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain 22: 499–504PubMedCrossRefGoogle Scholar
  48. 48.
    Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136: 873–883PubMedCrossRefGoogle Scholar
  49. 49.
    Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994) Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiol 5: 591–598CrossRefGoogle Scholar
  50. 50.
    Movig KLL, Mathijssen MPM, Nagel PHA, van Egmond T, de Gier JJ, Leufkens HGM, Egberts ACG (2004) Psychoactive substance use and the risk of motor vehicle accidents. Acc Anal Prev 36: 631–636CrossRefGoogle Scholar
  51. 51.
    Zacny JP, Gutierrez S (2003) Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacol 170: 242–254CrossRefGoogle Scholar
  52. 52.
    Zacny JP, Lichtor SA (2008) Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers. Psychopharmacol 196: 105–116CrossRefGoogle Scholar
  53. 53.
    O’Neill WM, Hanks GW, Simpson P, Fallon MT, Jenkins E, Wesnes K (2000) The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) doses of dextropropoxyphene, morphine, lorazepam, and placebo. Pain 85: 209–215PubMedCrossRefGoogle Scholar
  54. 54.
    Lorenz J, Beck H, Bromm B (1997) Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 73: 369–375PubMedCrossRefGoogle Scholar
  55. 55.
    Sjogren P, Olsen AK, Thomsen AB, Dalberg J (2000) Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain 86: 237–245PubMedCrossRefGoogle Scholar
  56. 56.
    Sjogren P, Thomsen AB, Olsen AK (2000) Impaired neuropsychological performance in chronic nonmalignant pain patient s receiving long-term oral opioid therapy. J Pain Symptom Manage 19: 100–108PubMedCrossRefGoogle Scholar
  57. 57.
    Dellemijn PLI, van Duijn H, Vanneste JAL (1998) Prolonged treatment with transdermal fentanyl in neuropathic pain. J Pain Symptom Manage 16: 220–229PubMedCrossRefGoogle Scholar
  58. 58.
    Kress HG, Kraft B (2005) Opioid medication and driving ability. Eur J Pain 2: 141–144CrossRefGoogle Scholar
  59. 59.
    Vainio A, Ollila J, Matikainen E, Rosenberg P, Kalso E (1995) Driving performance in cancer patients receiving long-term morphine analgesia. Lancet 346: 667–670PubMedCrossRefGoogle Scholar
  60. 60.
    Galski T, Williams B, Ehle HAT (2000) Effects of opioids on driving ability. J Pain Symp Manag 2000 19: 200–208CrossRefGoogle Scholar
  61. 61.
    Sabatowski R, Schwalen S, Rettig K, Herberg KW, Kasper SM, Radbruch L (2003) Driving ability under long-term treatment with transdermal fentanyl. J Pain Symp Manag 25: 38–47CrossRefGoogle Scholar
  62. 62.
    Byas-Smith MG, Chapman SL, Reed B, Cotsonis G (2005) The effects of opioids on driving and psychomotor performance in patients with chronic pain. Clin J Pain 21: 345–352PubMedCrossRefGoogle Scholar
  63. 63.
    Dagtekin O, Gerbershagen HJ, Wagner W, Petzke F, Radbruch L, Sabatowski R (2007) Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients. Anesth Analg 105: 1442–1448PubMedCrossRefGoogle Scholar
  64. 64.
    Gaertner J, Elsner F, Radbruch L, Kolibay F, Theusohn M, Berghaus G, Gerbershagen HJ, Dagtekin O, Sabatowski R (2008) Influence of changes to daily dose of opioids on aspects of cognitive and psychomotor performance involved in driving. Schmerz 22: 433–441PubMedCrossRefGoogle Scholar
  65. 65.
    Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS (2002) Can patients taking opioids drive safely? A structured evidence-based review. J Pain Palliative Care Pharmacother 16: 9–28CrossRefGoogle Scholar
  66. 66.
    Hanks GW (1995) Morphine sans Morpheus. Lancet 346: 652–653PubMedCrossRefGoogle Scholar
  67. 67.
    Zacny JP (1996) Should people taking opioids for medical reasons be allowed to work and drive? Addiction 91: 1581–1584PubMedCrossRefGoogle Scholar
  68. 68.
    Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352: 1331–1336PubMedCrossRefGoogle Scholar
  69. 69.
    Ramaekers JG (2003) Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 64: 20–29PubMedCrossRefGoogle Scholar
  70. 70.
    O’Hanlon JF, Robbe HW, Vermeeren A, van Leeuwen C, Danjou PE (1998) Venlafaxine’s effects on healthy volunteers’ driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. J Clin Psychopharm 18: 212–221CrossRefGoogle Scholar
  71. 71.
    Robbe HW, O’Hanlon JF (1995) Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol 5: 35–42PubMedCrossRefGoogle Scholar
  72. 72.
    Ramaekers JG, Muntjewerff ND, O’Hanlon JF (1995) A comparative study if acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 39: 397–404PubMedGoogle Scholar
  73. 73.
    Ramaekers JG, Swijgman HF, O’Hanlon JF (1992) Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacol 106: S62–S67CrossRefGoogle Scholar
  74. 74.
    Van Laar MW, van Willigenburg AP, Volkerts ER (1995) Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol 15: 30–40PubMedCrossRefGoogle Scholar
  75. 75.
    Veldhuijzen DS, van Wijck AJM, Verster JC, Kalkman CJ, Kenemans JL, Olivier B, Volkerts ER (2006) Acute and subchronic effects of amitriptyline 25 mg on actual driving in chronic neuropathic pain patients. J Psychopharmacol 20: 782–788PubMedCrossRefGoogle Scholar
  76. 76.
    Taylor CP (2004) The biology and pharmacology of calcium channel a2-a proteins. CNS Drug Rev 10: 183–188PubMedGoogle Scholar
  77. 77.
    Loring DW, Marino S, Meador KJ (2007) Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 17: 413–425PubMedCrossRefGoogle Scholar
  78. 78.
    Ramaekers JG, Lamers J, Verhey F, Muntjewerff D, Mobbs E, Sanders N, Lewis M, Lockton A (2002) A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic. Psychopharmacol 159: 203–210CrossRefGoogle Scholar
  79. 79.
    Tran KT, Hranicky D, Lark T, Jacob NJ (2005) Gabapentin withdrawal syndrome in the presence of a taper. Bipolar Disorders 7: 302PubMedCrossRefGoogle Scholar
  80. 80.
    Veldhuijzen DS, van Wijck AJM, Verster JC, Kalkman CJ, Kenemans JL, Olivier B, Volkerts ER (2006) The impact of patients’ psychotropic drug knowledge and warning labels on the decision whether to drive a car or not. Traffic Injury Prev 7: 360–364CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2009

Authors and Affiliations

  • Dieuwke S. Veldhuijzen
    • 1
  • Anne Mieke Karsch
    • 1
  • Albert J.M. van Wijck
    • 1
  1. 1.Pain Clinic, Division of Perioperative Care and Emergency MedicineUniversity Medical Center Utrecht, Rudolf Magnus Institute of NeurosciencesUtrechtThe Netherlands

Personalised recommendations